Both murine glioma GL261 and human GBM stem-like cells expressing high levels of GLAST (herein referred to as GLASThigh cells) appeared to be significantly more aggressive in terms of survival compared to the low GLAST-expressing cells (herein referred to as GLASTlow cells) after intracranial injection into mice. This evidence concerns the gene SLC1A3 and central nervous system cancer.